MACDIARMID J A,AMARO-MUGRIDGE N B,MADRID-WEISS J,et al.Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug[J].Nature Biotechnology,2009,27(7):643-651.
[2]
ANDERSSON M G,HAASNOOT P J,XU N,et al.Suppression of RNA interference by adenovirus virus-associated RNA[J].Journal of Virology,2005,79(15):9556-9565.
BOREL F,van LOGTENSTEIN R,KOORNNEEF A,et al.In vivo knock-down of multidrug resistance transporters ABCC1 and ABCC2 by AAV-delivered shRNAs and by artificial miRNAs[J].J RNAi Gene Silencing,2011,7:434-442.
[5]
van ES H H,ARTS G J.Biology calls the targets: Combining RNAi and disease biology[J].Drug Discovery Today,2005,10(20):1385-1391.
[6]
HUANG H Y,CHIANG B L.siRNA as a therapy for asthma[J].Curr Opin Mol Ther,2009,11(6):652-663.
[7]
LI Yang,LU Jin-feng,HAN Yan-hong,et al.RNA interference functions as an antiviral immunity mechanism in mammals[J].Science,2013,342(6155):231-234.
[8]
BRUMMELKAMP T R,BERNARDS R,AGAMI R A.System for stable expression of short interfering RNAs in mammalian cells[J].Science,2002,296(5567):550-553.
[9]
ZENG Y,WAGNER E J,CULLEN B R.Both natural and designed micro RNAs can inhibit the expression of cognate mRNAs when expressed in human cells[J].Molecular Cell,2002,9(6):1327-1333.
[10]
van GESTEL M A,van ERP S,SANDERS L E,et al.shRNA-induced saturation of the microRNA pathway in the rat brain[J].Gene Therapy,2014,21(2):205-211.
[11]
FELLMANN C,ZUBER J,MCJUNKIN K,et al.Functional identification of optimized RNAi triggers using a massively parallel sensor assay[J].Molecular Cell,2011,41(6):733-746.
[12]
PADDISON P J,SILVA J M,CONKLIN D S,et al.A resource for large-scale RNA-interference-based screens in mammals[J].Nature,2004,428(6981):427-431.
[13]
BOUDREAU R L,MONTEYS A M,DAVIDSON B L.Minimizing variables among hairpin-based RNAi vectors reveals the potency of shRNAs[J].Rna,2008,14(9):1834-1844.
[14]
STEGMEIER F,HU G,RICKLES R J,et al.A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells[J].Proceedings of the National Academy of Sciences of the United States of America,2005,102(37):13212-13217.
[15]
ZHOU J,LI B,PENG C,et al.Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes[J].Antiviral Research,2013,98(2):305-313.
[16]
CHUMAKOV S P,KRAVCHENKO J E,PRASSOLOV V S,et al.Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector[J].Plasmid,2010,63(3):143-149.
[17]
VIDIGAL J A,MORKEL M,WITTLER L,et al.An inducible RNA interference system for the functional dissection of mouse embryogenesis[J].Nucleic Acids Research,2010,38(11):e122.
[18]
DOW L E,PREMSRIRUT P K,ZUBER J,et al.A pipeline for the generation of shRNA transgenic mice[J].Nature Protocols,2012,7(2):374-393.
[19]
WHEELER L A,VRBAMAC V,TRIFONOVA R,et al.Durable knockdown and protection from HIV transmission in humanized mice treated with gel-formulated CD4 aptamer-siRNA chimeras[J].Molecular Therapy: The Journal of the American Society of Gene Therapy,2013,21(7):1378-1389.
SCHOPMAN N C,LIU Y P,KONSTANTINOVA P,et al.Optimization of shRNA inhibitors by variation of the terminal loop sequence[J].Antiviral Research,2010,86(2):204-211.
[22]
CHUMAKOV S P,KRAVCHENKO J E,PRASSOLOV V S,et al.Efficient downregulation of multiple mRNA targets with a single shRNA-expressing lentiviral vector[J].Plasmid,2010,63(3):143-149.
[23]
WU Jun-zhu,LIU Shi-he,YU Jian,et al.Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platform[J].Cancer Gene Ther,2014,21(2):48-53.
[24]
WU Jun-zhu,BONSRA A N,DU Guang-wei.pSM155 and pSM30 vectors for miRNA and shRNA expression[M]. Totowa:Humana Press,2009:1-15.
YUE Jun-ming,SHENG Yi,REN Ai-xia,et al.A miR-21 hairpin structure-based gene knockdown vector[J].Biochemical and Biophysical Research Communications,2010,394(3):667-672.
[27]
CHEN S C Y,STERN P,GUO Zhu-yan,et al.Expression of multiple artificial microRNAs from a chicken miRNA126-based lentiviral vector[J].PloS One,2011,6(7):e22437.
[28]
LEE N S,DOHJIMA T,BAUER G,et al.Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells[J].Nature Biotechnology,2002,20(5):500-505.
[29]
CHEN Chang-zhen,LI Ling,LODISH H F,et al.MicroRNAs modulate hematopoietic lineage differentiation[J].Science,2004,303(5654):83-86.
[30]
SILVA J M,LI M Z,CHANG K,et al.Second-generation shRNA libraries covering the mouse and human genomes[J].Nat Genet,2005,37(11):1281-1288.
[31]
MOFFAT J,GRUENEBERG D A,YANG X,et al.A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen[J].Cell,2006,124(6):1283-1298.
[32]
BOUDREAU R L,MARTINS I,DAVIDSON B L.Artificial microRNAs as siRNA shuttles: Improved safety as compared to shRNAs in vitro and in vivo[J].Molecular Therapy:The Journal of the American Society of Gene Therapy,2009,17(1):169-175.
[33]
CHUNG K H,HART C C,AL-BASSAM S,et al.Polycistronic RNA polymerase Ⅱ expression vectors for RNA interference based on BIC/miR-155[J].Nucleic Acids Research,2006,34(7):e53.
[34]
WILSON R C,DOUDNA J A.Molecular mechanisms of RNA interference[J].Annual Review of Biophysics,2013,42:217-239.
QAZI Y,STAGG B,SINGH N,et al.Nanoparticle-mediated delivery of shRNA.VEGF-a plasmids regresses corneal neovascularization[J].Investigative Ophthalmology and Visual Science,2012,53(6):2837-2844.
[37]
HAN Lu,TANG Cui,YIN Chun-hua.Oral delivery of shRNA and siRNA via multifunctional polymeric nanoparticles for synergistic cancer therapy[J].Biomaterials,2014,35(15):4589-4600.
MACDIARMID J A,MUGRIDGE N B,WEISS J C,et al.Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics[J].Cancer Cell,2007,11(5):431-445.
[40]
KEATES A C,FRUEHAUF J H,XIANG Shuang-lin,et al.Cequent Pharmaceuticals, Inc: The biological pitcher for RNAi therapeutics[J].Pharmacogenomics,2007,8(7):867-871.
